University of South Florida
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of South Florida sits in the top decile of US sponsors by registered trial count (#131 of 15,742 sponsors by registered trial count).
University of South Florida: 252 sponsored US clinical trials, 44 recruiting.
University of South Florida sponsors 252 registered US clinical trials on ClinicalTrials.gov, 44 of them currently recruiting, and 171 completed. 32 of these trials are in Phase 3-4 (later-stage) and 40 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obsessive - Compulsive Disorder, with 4 trials.
Top-decile sponsor footprint
University of South Florida ranks in the top decile of sponsors by registered trial count (#131 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
171 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
252 total, page 3 of 6
Development of a Behavioral Outcome Measure for Rett Syndrome (RettBe)
NCT03196323
Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy
NCT02960412
Hemodynamic Assessment of Distal Revascularization Interval Ligation
NCT03054623
Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome
NCT02872077
Veress Entry With/Without Concomitant CO2
NCT02896036
Prosthetic Socket Interface Design on Socket Comfort, Residual Limb Health, and Function for the Transfemoral Amputee
NCT02773056
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
NCT02788734
Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2
NCT02793063
Intimate Partner Violence and Fatherhood Intervention in Residential Substance Abuse Treatment
NCT02979262
Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors
NCT02786797
Worksite Exercise Interventions for Low Back Injury Prevention in Firefighters
NCT02362243
ACELL Mesh for Paraesophageal Hernia Repair
NCT03058731
iStride(TM) Device Used for Stroke Rehabilitation
NCT02185404
Virtual Reality Prosthetic Training and Rehabilitation
NCT02666859
The SNORES Randomized Clinical Trial
NCT02442999
Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older
NCT02960399
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy
NCT02472184
Randomized Controlled Trial of Prenatal Coparenting Intervention (CoparentRCT)
NCT03097991
Stepped Care for Children After Trauma: Optimizing Treatment
NCT02537678
Impact of Vasculitis on Employment and Income
NCT02476292
The Impact of Piano Training on Cognitive Performance and Psychosocial Well-Being in Older Adults
NCT02564601
Prospective Evaluation of Lingual Frenotomy in Newborns With Simultaneous Lip Tie for the Relief of Breastfeeding Pain.
NCT02141243
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
NCT02108860
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
NCT02283294
Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship
NCT01883089
Frequency of Oral Care Intervention Study
NCT02289131
Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies
NCT02151318
Pilot Study: Urea Cycle Disorders Practice Patterns and Outcomes Assessment
NCT02311283
Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT02465359
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
NCT02311270
Survey on Supplement Use in Mitochondrial Disease
NCT02311257
Predictors of Lactogenesis II
NCT02220413
Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
NCT02134756
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942
Postpartum Weight Loss and Sleep Amongst Obese Women
NCT01968330
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
NCT02028247
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
NCT02099370
Cluster Randomized Trial Comparing Interventions to Enhance Genetic Counseling Among Breast Cancer Patients
NCT01789684
Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies
NCT02062151
Brief Behavioral Treatment for Anxiety in Young Children
NCT02051192
Defining Sexual Activity
NCT02085746
Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes
NCT02013557
Targeting Caregivers to Enhance Health Behaviors in Pediatric Cancer Survivors
NCT02815982
Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma
NCT02030522
EPI-743 in Friedreich's Ataxia Point Mutations
NCT01962363
Stepped Care Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
NCT01981317
Prospective Study on Cesarean Wound Outcomes
NCT01697748
Functional Performance of Voluntary Opening and Closing Body Powered Prostheses
NCT02136238
Patient Outcomes of a Self-care Management Approach to Cancer Symptoms: A Clinical Trial
NCT02288169
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
NCT01923584
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 29 |
| Phase 3 | 18 |
| Phase 4 | 14 |
What is open in the University of South Florida pipeline
44 recruiting of 252 indexed (17% open); 171 completed (68%).
Phase mix: 32 late (III/IV) vs 40 early (I/II) (balanced across stages).
Top condition: Obsessive - Compulsive Disorder (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of South Florida: open-pipeline peers nationwide
Peers matched on 252 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of South Florida sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 252 trials (± recruiting share)
- Boston Medical Center · 253 trials · 11% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
Sponsors near 17% open enrollment (± trial volume)
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- Indiana University · 18% recruiting · 890 trials
- ImmunityBio · 17% recruiting · 46 trials
- Old Dominion University · 17% recruiting · 23 trials
Related
What to do with this University of South Florida page
252 registered trials is a research-attention snapshot, not an endorsement of University of South Florida or any single study.
- 44 of University of South Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obsessive - Compulsive Disorder is the condition University of South Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obsessive - Compulsive Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of South Florida pipeline card: 252 registered trials from official public datasets.Report a data error.